By Adam Nossiter Reporting from Paris The one-on-one duel that has shaped French political life for nearly a decade ratcheted up a notch last week, with the far-right leader Marine Le Pen claiming ...

After slashing the U.S. prices of several of its insulin products by 75% at the start ... which is a pre-filled, disposable pen, will fall from $559 to $140. For Tresiba’s U-100 FlexTouch ...

A federal jury has sided with Insulet, which claimed that the South Korea-based diabetes tech company EOFlow had stolen trade secrets related to its wearable insulin pump, in a case that ...

The medical device manufacturer Owen Mumford has announced that it will stop producing its Autopen range of insulin delivery pens. Here, we look at what this means for people with diabetes who might ...

In our November research highlights, we look at how diet in early childhood is linked to the risk of type 2 diabetes years later, and how new clinical trials are looking to give people with type 1 ...

At Camarillo State Hospital, he worked off and on at the “insulin shock ward” from 1939 to 1941. It was a 20-bed dorm for the treatment of schizophrenia in the desperate era before ...

In July, Embecta, a manufacturer of disposable insulin pen needles and syringes, said it is considering a potential sale following a significant drop in its share price since being spun off from ...

It combines the company’s InPen smart insulin pen with its Simplera continuous glucose monitor (CGM), a disposable, all-in-one device. The MDI system is poised to be the first on the market to ...

Novo Nordisk is gradually ending production of human insulin pens, a spokesperson confirmed to Reuters. Instead, the company is channeling investments into manufacturing its popular obesity and ...

No­vo Nordisk said Thurs­day that it plans to even­tu­al­ly halt all of its hu­man in­sulin pen pro­duc­tion glob­al­ly, con­firm­ing an End­points News ...

A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard for treating diabetes patients. Dr Vincent Simpson aims to cut down on ...